Core Insights - The Chemours Company reported a net loss of $47 million or 31 cents per share for Q4 2025, a significant decline from the previous year's net loss of $11 million or 8 cents [1] - Adjusted EBITDA decreased by 24% year over year to $128 million, primarily due to weaker performance in Titanium Technologies and Advanced Performance Materials segments [3] Financial Performance - Q4 net sales were $1,329 million, reflecting a 2.2% decline from the previous year, in line with Zacks Consensus Estimate [2] - Cash provided by operating activities was $137 million, slightly down from $138 million in the prior quarter, while capital expenditures were reduced to $45 million from $109 million year over year [8] Segment Performance - Titanium Technologies division revenues were $561 million, an 11% decrease year over year, but exceeded estimates [4] - Thermal & Specialized Solutions segment saw a 14% year-over-year revenue increase to $444 million, driven by higher prices and volume [5] - Advanced Performance Materials unit revenues amounted to $312 million, a 4% decline year over year, primarily due to an 8% decrease in volume [7] Outlook - The company expects Q1 sales to increase by 3-5% sequentially, with full-year sales growth projected at 3-5% year over year [9] - Adjusted EBITDA is anticipated to be between $120-$150 million for Q1 and $800-$900 million for 2026 [9] - The Titanium Technologies segment is expected to see a sequential decline in net sales, while Thermal & Specialized Solutions is projected to experience a mid-20 to 30% sequential increase [11][12] Stock Performance - Chemours shares have gained 5.5% over the past year, contrasting with a 13.4% decline in the industry [13]

Core Viewpoint - The Chemours Company reported a net loss of $4 million for Q1 2025, a significant decline from a net income of $54 million in the same quarter last year, indicating challenges in profitability despite a slight increase in net sales [1]. Financial Performance - The company achieved first-quarter net sales of $1,368 million, reflecting a 1.3% increase year-over-year and surpassing the Zacks Consensus Estimate of $1,355.2 million, driven by a 5% increase in volume despite a 4% drop in pricing and a 1% negative currency impact [2]. - Adjusted EBITDA for the quarter declined by 13% year-over-year to $166 million, primarily due to lower pricing across business segments, particularly in Thermal & Specialized Solutions and Titanium Technologies [3]. Segment Highlights - The Titanium Technologies division reported revenues of $597 million, a 1% increase from the previous year, exceeding the estimate of $579.2 million, attributed to a 6% increase in volumes, offset by a 4% decrease in price [3]. - The Thermal & Specialized Solutions segment saw revenues of $466 million, a 3% year-over-year increase, but fell short of the estimate of $479.2 million, with net sales growth driven by a 10% increase in volume, slightly offset by a 6% price decline [4]. - Revenues in the Advanced Performance Materials unit amounted to $294 million, a decline of approximately 3% year-over-year, yet beating the estimate of $289.4 million, with a 1% drop in volume and a 2% currency headwind [5]. Cash Flow and Capital Expenditures - Cash used by operating activities in Q1 2025 was $112 million, down from $290 million in the prior-year quarter, while capital expenditures were $84 million compared to $102 million in the previous year [6]. - The company reduced its dividend by 65% to $0.0875 per share to align with its capital allocation strategy [6]. Outlook - The company anticipates consolidated net sales to increase in the low to mid-teens sequentially in Q2, with adjusted EBITDA expected to rise by 40% to 45% [7]. - Full-year 2025 adjusted EBITDA is projected to be between $825 million and $950 million, with capital expenditures expected to range from $225 million to $275 million [7]. Stock Performance - Chemours shares have declined by 61.4% over the past year, compared to a 28.3% decline in the industry [8].